Target intelligence / Profile preview

Tryptophan synthase beta chain (TrpB)

Target
TrpB
Molecular classification
Enzyme, Lyase, Pyridoxal-phosphate-dependent enzyme
01

Overview

The tryptophan synthase beta chain (TrpB) is an enzyme subunit that catalyzes the last step in the biosynthesis of L-tryptophan, converting indole and L-serine into L-tryptophan in a reaction requiring the cofactor pyridoxal phosphate[3][4][5][6][7][8]. This subunit forms part of the tryptophan synthase complex, which typically operates as an α₂β₂ tetramer in bacteria and other non-mammalian organisms. The beta chain (TrpB) is responsible for the beta elimination and subsequent condensation of indole with L-serine. TrpB is found in bacteria, archaea, fungi, and plants, but not in animals, as the latter acquire tryptophan through diet. The enzyme's beta chain exists in at least two phylogenetically distinct subgroups (TrpEb_1 and TrpEb_2), and in certain Archaea, the minor group (TrpEb_2) may additionally catalyze L-serine deamination[2]. TrpB requires pyridoxal-phosphate (PLP) as a cofactor, which is covalently attached to a lysine residue within the active site[5][6]. Caveats: There is no evidence for a role in human disease as a direct target, and it is not clinically targeted by approved therapies; however, it is a validated enzymatic step in the microbial syntheses of tryptophan and thus has potential in antibacterial drug discovery[2][3].

Other names
Tryptophan synthase TrpBTrpBTryptophan synthase beta subunitTryptophan synthase subunit beta
02

Mechanism of action

No drugs in clinical use; in research, inhibitors would likely act via competitive or allosteric inhibition of enzymatic function.

03

Biological functions

Amino acid biosynthesis (specifically, L-tryptophan biosynthesis)Catalysis of L-tryptophan formation from indole and L-serineIn some lineages, it also functions in L-serine deamination
04

Disease associations

Other (No established disease association, but bacterial tryptophan biosynthesis could be a target in anti-infective drug discovery since mammals lack this pathway)

Beyond the preview

Go deeper on Tryptophan synthase beta chain (TrpB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tryptophan synthase beta chain (TrpB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call